Validation of a commercially available indirect assay for SARS-CoV-2 neutralising antibodies using a pseudotyped virus assay (2021)

First Author: Murray M

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jinf.2021.03.010

PubMed Identifier: 33753152

Publication URI: http://europepmc.org/abstract/MED/33753152

Type: Journal Article/Review

Parent Publication: Journal of Infection

Issue: 5

ISSN: 0163-4453